id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-341999-nosdj7b2	Conti, A.	Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs	2020-05-07		.txt	text/plain	604	19	32	However, few reports are available on the course of COVID-19 infection in psoriatic patients treated with biological drugs (2) . key: cord-341999-nosdj7b2 authors: Conti, A.; Lasagni, C.; Bigi, L.; Pellacani, G. title: Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs date: 2020-05-07 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16587 sha: doc_id: 341999 cord_uid: nosdj7b2 Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1).	cache/cord-341999-nosdj7b2.txt	txt/cord-341999-nosdj7b2.txt
